Vassilios Aslanis

3PUBLICATIONS
5CO-AUTHORS
Characterisation of biological macromoleculesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 02, 2024
Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic Impairment.

Vassilios Aslanis, Michael Gray, Robert J Slack

|Aug 21, 2024
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1).

Vassilios Aslanis, Khalid Abd-Elaziz, Robert J Slack

|Mar 14, 2023
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants.

Vassilios Aslanis, Robert J Slack, Alison C MacKinnon

Pageof 1

Frequent Collaborators

3 joint publications

Robert J Slack

2 joint publications

Fredrik R Zetterberg

1 joint publications

Khalid Abd-Elaziz

1 joint publications

Kimberly Herman